Serum indoxyl sulfate predicts adverse cardiovascular events in patients with chronic kidney disease
ConclusionIS may have a critical role in the prediction of CV disease in patients with CKD. Further large-scale investigations are warranted and suggested.
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research
More News: Cardiology | Cardiovascular | Chia | Chronic Kidney Disease | General Medicine | Heart | Study | Toxicology | Urology & Nephrology